Completion of the Share Capital Decrease of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Co.
التاريخ
Ref. : 8/11/891
Date: 18/02/2019
Memo No.
(14/2019)
Members of SDC of Brokers and Custodians
Dear General Manager,
Subject: Completion of the Share Capital Decrease of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Co.
Greetings,
Kindly be informed that the SDC has completed the process of decreasing the share capital of the Completion of the Share Capital Decrease of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company on Monday 18/02/2019 to redeem the accumulated losses as of 31/12/2017. The share capital decrease was conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 31/07/2018, and upon the approval of the Ministry of Industry, Trade, and Supply on the share capital decrease issued on 31/01/2019.
Thereby, the SDC record for the Capital of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company indicates the following:
Kindly be informed that the SDC has completed the process of decreasing the share capital of the Completion of the Share Capital Decrease of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company on Monday 18/02/2019 to redeem the accumulated losses as of 31/12/2017. The share capital decrease was conducted based upon the company's General Assembly's resolution made in its extraordinary meeting held on 31/07/2018, and upon the approval of the Ministry of Industry, Trade, and Supply on the share capital decrease issued on 31/01/2019.
Thereby, the SDC record for the Capital of the Middle East Pharmaceutical & Chemical Industries & Medical Appliances Company indicates the following:
| # | Company Name | No. of shares decreased | Registered Share Capital |
ISIN
|
Company No. |
| 1. | Middle East Pharmaceutical & Chemical Industries & Medical Appliances Co. | 8,619,000 | 1,250,583 | JO4107311014 | 141073 |
Kind Regards,
Khalil Naser
Chief Executive Officer
